GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427401. A total of 5 filers reported holding GENOCEA BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $244,000 | -45.8% | 195,000 | -49.7% | 0.00% | – |
| Q4 2021 | $450,000 | +202.0% | 387,600 | +400.1% | 0.00% | – |
| Q3 2021 | $149,000 | -62.4% | 77,500 | -54.1% | 0.00% | – |
| Q2 2021 | $396,000 | -53.2% | 168,900 | -45.9% | 0.00% | – |
| Q1 2021 | $846,000 | -39.5% | 312,300 | -45.9% | 0.00% | – |
| Q4 2020 | $1,398,000 | +117.1% | 577,000 | +105.1% | 0.00% | – |
| Q3 2020 | $644,000 | +152.5% | 281,358 | +154.0% | 0.00% | – |
| Q2 2020 | $255,000 | +129.7% | 110,782 | +72.3% | 0.00% | – |
| Q1 2020 | $111,000 | +428.6% | 64,308 | +536.7% | 0.00% | – |
| Q4 2019 | $21,000 | -82.9% | 10,100 | -76.2% | 0.00% | – |
| Q3 2019 | $123,000 | -72.4% | 42,354 | -62.8% | 0.00% | – |
| Q2 2019 | $445,000 | – | 113,722 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,765,901 | $4,273,000 | 2.32% |
| NEA Management Company, LLC | 10,376,936 | $25,112,000 | 0.66% |
| Polaris Venture Management Co. V, L.L.C. | 197,345 | $478,000 | 0.62% |
| ABG Innovation Capital Partners III GP Ltd | 375,000 | $908,000 | 0.54% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,972,056 | $4,772,000 | 0.52% |
| BVF INC/IL | 4,012,404 | $9,710,000 | 0.38% |
| Avoro Capital Advisors LLC | 5,084,184 | $12,304,000 | 0.21% |
| FNY Investment Advisers, LLC | 200,000 | $484,000 | 0.13% |
| Boxer Capital, LLC | 1,134,453 | $2,745,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 130,745 | $316,000 | 0.05% |